Charles Schwab Investment Management Inc Novavax Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Novavax Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,365,414 shares of NVAX stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,365,414
Previous 1,325,508
3.01%
Holding current value
$10.8 Million
Previous $16.7 Million
34.43%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$124 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$93.5 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$88 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$60.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$45.7 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $617M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...